Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Significant potential of late- and mid-stage Novartis hematology portfolio to ... - PR Newswire (press release) |
![]() |
![]() |
PR Newswire (press release)Patients with moderate renal impairment (CrCL = 20-39 mL/min) should receive a 50% decrease in the recommended starting dose, and future doses can be ...Significant potential of late- and mid-stage Novartis hematology portfolio to ... read more |